Clinical Trials Logo

Psychoses clinical trials

View clinical trials related to Psychoses.

Filter by:

NCT ID: NCT00159133 Completed - Schizophrenia Clinical Trials

Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia

Start date: November 2001
Phase: Phase 4
Study type: Interventional

Prodrome based early intervention with an antipsychotic drug vs. benzodiazepine was applied in patients with first episode schizophrenia after one year neuroleptic maintenance treatment. Two groups of patients were followed over a period of 1 year: one further on under maintenance neuroleptic treatment, the other one after stepwise drug discontinuation.

NCT ID: NCT00159120 Completed - Schizophrenia Clinical Trials

Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia

Start date: November 2001
Phase: Phase 4
Study type: Interventional

After one year neuroleptic maintenance treatment in patients with first episode schizophrenia, neuroleptic treatment will be continued vs. stepwise discontinued (randomized design) over a period of 1 year. Under both conditions prodrome based early intervention take place.

NCT ID: NCT00095810 Completed - Parkinson's Disease Clinical Trials

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Start date: July 2003
Phase: Phase 4
Study type: Interventional

The purpose of this clinical research study is to assess the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.

NCT ID: NCT00087542 Completed - Parkinson's Disease Clinical Trials

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Start date: March 2004
Phase: Phase 2
Study type: Interventional

The primary objective is to demonstrate that the investigational new drug, ACP-103, is well tolerated by, and will not worsen parkinsonism in, patients with Parkinson's disease and psychosis. The secondary objectives are to determine whether ACP-103 will ameliorate psychosis in patients with Parkinson's disease and whether ACP-103 is safe in Parkinson's disease patients taking multiple anti-parkinsonian medications.

NCT ID: NCT00070889 Completed - Psychoses Clinical Trials

Brain Cell Injury in Patients With A First Episode of Psychosis

Start date: September 1999
Phase: N/A
Study type: Observational

Patients experiencing a first episode of psychosis may have brain cell damage due to a chemical process called oxidation. This study will compare patients with psychosis to healthy volunteers to determine if there are differences in their blood that reflect oxidative brain cell damage.